TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

cGMP Facility Streamlines Clinical & Commercial mRNA Drug Substance Development;
Built by mRNA & Industry Experts to Meet Demand for mRNA-based Medicine

...

Related Keywords

San Diego ,California ,United States ,Kevin Lynch ,Maravai Lifesciences ,Exchange Commission ,Nasdaq ,Trilink Biotechnologies ,Link Biotechnologies ,Cuts Ribbon ,New San Diego Facility ,Late Phase ,Substance Production ,Sorrento Valley ,Vice President ,General Manager ,Drew Burch ,Nucleic Acid ,Securities Litigation Reform Act ,Annual Report ,